☰

Irfan A. Khan, PhD - Publications

Affiliations: 
2014-2017 Chemistry State University of New York, Albany, Albany, NY, United States 
Area:
Molecular cell biology, Cancer medicine and Nanotechnology
Website:
http://www.royzenlab.science/
Tree Info Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Uyar TB, Wu K, He M, Khan I, Royzen M, Yigit MV. Switchable fluorescence of doxorubicin for label-free imaging of bioorthogonal drug release. Chemmedchem. PMID 32216081 DOI: 10.1002/Cmdc.202000065  0.7
2019 Wu K, He M, Khan I, Asare Okai PN, Lin Q, Fuchs G, Royzen M. Bio-orthogonal chemistry-based method for fluorescent labelling of ribosomal RNA in live mammalian cells. Chemical Communications (Cambridge, England). PMID 31411211 DOI: 10.1039/C9Cc05346H  0.663
2018 Czuban M, Srinivasan S, Yee NA, Agustin E, Koliszak A, Miller E, Khan I, Quinones I, Noory H, Motola C, Volkmer R, Di Luca M, Trampuz A, Royzen M, Mejia Oneto JM. Bio-Orthogonal Chemistry and Reloadable Biomaterial Enable Local Activation of Antibiotic Prodrugs and Enhance Treatments against Infections. Acs Central Science. 4: 1624-1632. PMID 30648146 DOI: 10.1021/Acscentsci.8B00344  0.688
2017 Khan I, Seebald LM, Robertson NM, Yigit MV, Royzen M. Controlled in-cell activation of RNA therapeutics using bond-cleaving bio-orthogonal chemistry. Chemical Science. 8: 5705-5712. PMID 28989610 DOI: 10.1039/C7Sc01380A  0.673
2017 Robertson NM, Yang Y, Khan I, LaMantia VE, Royzen M, Yigit MV. Single-trigger dual-responsive nanoparticles for controllable and sequential prodrug activation. Nanoscale. PMID 28682403 DOI: 10.1039/C7Nr04138A  0.708
2016 Mejia Oneto JM, Khan I, Seebald L, Royzen M. In Vivo Bioorthogonal Chemistry Enables Local Hydrogel and Systemic Pro-Drug To Treat Soft Tissue Sarcoma. Acs Central Science. 2: 476-82. PMID 27504494 DOI: 10.1021/Acscentsci.6B00150  0.655
2016 Khan I, Agris PF, Yigit MV, Royzen M. In situ activation of a doxorubicin prodrug using imaging-capable nanoparticles. Chemical Communications (Cambridge, England). PMID 27076271 DOI: 10.1039/C6Cc01024E  0.683
2015 Agustin E, Asare Okai PN, Khan I, Miller MR, Wang R, Sheng J, Royzen M. A fast click-slow release strategy towards the HPLC-free synthesis of RNA. Chemical Communications (Cambridge, England). PMID 26619912 DOI: 10.1039/C5Cc05392G  0.655
2013 Siddiqui S, Khan I, Zarina S, Ali S. Use of the SYBR Green dye for measuring helicase activity. Enzyme and Microbial Technology. 52: 196-8. PMID 23410932 DOI: 10.1016/J.Enzmictec.2012.12.008  0.568
2012 Khan IA, Siddiqui S, Rehmani S, Kazmi SU, Ali SH. Fluoroquinolones inhibit HCV by targeting its helicase. Antiviral Therapy. 17: 467-76. PMID 22293206 DOI: 10.3851/Imp1937  0.657
2012 Khan IA, Siddiqui S, Rehmani S, Kazmi SU, Ali SH. Fluoroquinolones inhibit HCV by targeting its helicase (Antiviral Therapy (2012) 17, (595)) Antiviral Therapy. 17: 595. DOI: 10.3851/Imp1943  0.64
2011 Kassi M, Afghan AK, Khanani MR, Khan IA, Ali SH. Safe blood transfusion practices in blood banks of Karachi, Pakistan. Transfusion Medicine (Oxford, England). 21: 57-62. PMID 21029219 DOI: 10.1111/J.1365-3148.2010.01042.X  0.426
Show low-probability matches.